Vivos Therapeutics, Inc. (VVOS) Discusses Strategic Business Model Pivot and Transition in Sleep Apnea Treatment Approach Transcript [Seeking Alpha]
Vivos Therapeutics, Inc. (VVOS)
Company Research
Source: Seeking Alpha
Company Participants R. Huntsman - Co-Founder, Chairman of the Board & CEO Bradford Amman - CFO, Treasurer & Secretary Conference Call Participants Robert Sassoon - Water Tower Research LLC Presentation Robert Sassoon Water Tower Research LLC Hello, everybody. I'm Robert Sassoon, healthcare analyst at Water Tower Research. I have the double pleasure of hosting Kirk Huntsman, CEO of Vivos Therapeutics; and Brad Amman, the company's CFO, for this fireside chat. Vivos is a revenue stage medical technology company focused on developing and commercializing a suite of innovative diagnostic and nonsurgical treatment methods for patients suffering from breathing and sleep issues arising from certain dentofacial abnormalities, primarily obstructive sleep apnea or OSA, often referred to as the silent killer, and is estimated to affect as many as 90 million people in the U.S., 1 billion worldwide. The stock trades on the NASDAQ under the ticker VVOS. You can find the company's
Show less
Read more
Impact Snapshot
Event Time:
VVOS
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VVOS alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VVOS alerts
High impacting Vivos Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VVOS
News
- Vivos Therapeutics Announces Grand Opening of Affiliated Sleep Center Near Detroit, MichiganGlobeNewswire
- Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am EST [Yahoo! Finance]Yahoo! Finance
- Vivos Therapeutics to Participate in Online Fireside Chat with Water Tower Research on December 16, 2025, at 11 am ESTGlobeNewswire
- Vivos Therapeutics (NASDAQ:VVOS) had its price target lowered by analysts at Ascendiant Capital Markets from $6.50 to $5.50. They now have a "buy" rating on the stock.MarketBeat
- Vivos Therapeutics (NASDAQ:VVOS) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.MarketBeat
VVOS
Earnings
- 11/19/25 - Beat
VVOS
Sec Filings
- 12/17/25 - Form 8-K
- 12/5/25 - Form 8-K
- 11/19/25 - Form 8-K
- VVOS's page on the SEC website